303 related articles for article (PubMed ID: 12153599)
1. Effect of methyl testosterone administration on plasma viscosity in postmenopausal women.
Basaria S; Nguyen T; Rosenson RS; Dobs AS
Clin Endocrinol (Oxf); 2002 Aug; 57(2):209-14. PubMed ID: 12153599
[TBL] [Abstract][Full Text] [Related]
2. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses.
Sarrel P; Dobay B; Wiita B
J Reprod Med; 1998 Oct; 43(10):847-56. PubMed ID: 9800666
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women.
Simon J; Klaiber E; Wiita B; Bowen A; Yang HM
Menopause; 1999; 6(2):138-46. PubMed ID: 10374221
[TBL] [Abstract][Full Text] [Related]
4. Influence of methyltestosterone postmenopausal therapy on plasma lipids, inflammatory factors, glucose metabolism and visceral fat: a randomized study.
Leão LM; Duarte MP; Silva DM; Bahia PR; Coeli CM; de Farias ML
Eur J Endocrinol; 2006 Jan; 154(1):131-9. PubMed ID: 16382002
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy improves cardiovascular risk by lowering plasma viscosity in postmenopausal women.
Rosenson RS; Tangney CC; Mosca LJ
Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1902-5. PubMed ID: 9848882
[TBL] [Abstract][Full Text] [Related]
6. Effect of the combination of methyltestosterone and esterified estrogens compared with esterified estrogens alone on apolipoprotein CIII and other apolipoproteins in very low density, low density, and high density lipoproteins in surgically postmenopausal women.
Chiuve SE; Martin LA; Campos H; Sacks FM
J Clin Endocrinol Metab; 2004 May; 89(5):2207-13. PubMed ID: 15126543
[TBL] [Abstract][Full Text] [Related]
7. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
[TBL] [Abstract][Full Text] [Related]
8. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group.
Pasquali R; Vicennati V; Bertazzo D; Casimirri F; Pascal G; Tortelli O; Labate AM
Metabolism; 1997 Jan; 46(1):5-9. PubMed ID: 9005961
[TBL] [Abstract][Full Text] [Related]
9. Effect of postmenopausal estrogen replacement on circulating androgens.
Casson PR; Elkind-Hirsch KE; Buster JE; Hornsby PJ; Carson SA; Snabes MC
Obstet Gynecol; 1997 Dec; 90(6):995-8. PubMed ID: 9397118
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of high-dose estrogen and high-dose estrogen plus methyltestosterone treatment on cognitive task performance in postmenopausal women.
Wisniewski AB; Nguyen TT; Dobs AS
Horm Res; 2002; 58(3):150-5. PubMed ID: 12218381
[TBL] [Abstract][Full Text] [Related]
11. The effects of six months of treatment with a low-dose of conjugated oestrogens in menopausal women.
Schlegel W; Petersdorf LI; Junker R; Schulte H; Ebert C; Von Eckardstein A
Clin Endocrinol (Oxf); 1999 Nov; 51(5):643-51. PubMed ID: 10594527
[TBL] [Abstract][Full Text] [Related]
12. The benefits of androgens combined with hormone replacement therapy regarding to patients with postmenopausal sexual symptoms.
de Paula FJ; Soares JM; Haidar MA; de Lima GR; Baracat EC
Maturitas; 2007 Jan; 56(1):69-77. PubMed ID: 16822626
[TBL] [Abstract][Full Text] [Related]
13. Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause.
Watts NB; Notelovitz M; Timmons MC; Addison WA; Wiita B; Downey LJ
Obstet Gynecol; 1995 Apr; 85(4):529-37. PubMed ID: 7898828
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire.
Lobo RA; Rosen RC; Yang HM; Block B; Van Der Hoop RG
Fertil Steril; 2003 Jun; 79(6):1341-52. PubMed ID: 12798881
[TBL] [Abstract][Full Text] [Related]
15. Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapy.
Kwok S; Selby PL; McElduff P; Laing I; Mackness B; Mackness MI; Prais H; Morgan J; Yates AP; Durrington PN; Sci FM
Clin Endocrinol (Oxf); 2004 Dec; 61(6):760-7. PubMed ID: 15579192
[TBL] [Abstract][Full Text] [Related]
16. Effect of micronized progesterone on bone turnover in postmenopausal women on estrogen replacement therapy.
Azizi G; Hansen A; Prestwood KM
Endocr Res; 2003 May; 29(2):133-40. PubMed ID: 12856800
[TBL] [Abstract][Full Text] [Related]
17. Effect of estrogen-progestin replacement therapy on plasma lipids and lipoproteins in postmenopausal women.
Rodriguez-Alemán F; Torres JM; Cuadros JL; Ruiz E; Ortega E
Endocr Res; 2000 May; 26(2):263-73. PubMed ID: 10921452
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in postmenopausal women.
Dobs AS; Nguyen T; Pace C; Roberts CP
J Clin Endocrinol Metab; 2002 Apr; 87(4):1509-16. PubMed ID: 11932273
[TBL] [Abstract][Full Text] [Related]
19. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
Fertil Steril; 2001 Mar; 75(3):554-9. PubMed ID: 11239541
[TBL] [Abstract][Full Text] [Related]
20. Combined esterified estrogens and methyltestosterone versus esterified estrogens alone in the treatment of loss of sexual interest in surgically menopausal women.
Warnock JK; Swanson SG; Borel RW; Zipfel LM; Brennan JJ;
Menopause; 2005; 12(4):374-84. PubMed ID: 16037752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
